Tae Ho Kim1,2, Jae Seung Chang1,2, Kyu-Sang Park1, Jeeyeon Park3, Nahyun Kim4, Jong In Lee5, In Deok Kong1,2. 1. Department of Physiology, Wonju College of Medicine, Yonsei University, Wonju, Republic of Korea. 2. Yonsei Institute of Sports Science & Exercise Medicine, Wonju, Republic of Korea. 3. Department of Nursing Science, Kyungsung University, Busan, Republic of Korea. 4. Department of Basic Nursing Science, Keimyung University College of Nursing, Daegu, Republic of Korea. 5. Department of Hematology-Oncology, Wonju College of Medicine, Yonsei University, Wonju, Republic of Korea.
Abstract
BACKGROUND:Wingless and integration site growth factor (Wnt) signaling is a tumorigenesis-related signaling pathway. Dickkpof-1 (DKK1) and secreted frizzled-related protein-1 (SFRP1) are endogenous negative regulators of Wnt/β-catenin signaling. Accumulating evidence indicates that higher serum levels of DKK1 are correlated with poor prognosis of various types of cancer. Here, we investigated whether exercise training causes changes in the serum levels of DKK1 and SFRP1 in patients with breast cancer. METHODS:Twenty-four breast cancer survivors, after chemo- or radiotherapy, participated in this single-blind randomized, controlled pilot study. Subjects were randomized to either an exercise program or a control group for 12 weeks and completed pre- and post-training tests for health-related fitness and body composition as well as blood biomarkers. The serum levels of DKK1 and SFRP1 were measured using enzyme-linked immunosorbent assay as the primary outcome. RESULTS:Exercise training for 12 weeks remarkably increased muscle strength, endurance, and flexibility and decreased body fat percentage, waist circumference, and visceral fat area (all p < 0.05). Exercise training lowered serum insulin levels and leptin/adiponectin ratios (all p < 0.05). The levels of DKK1 and SFRP1 were also significantly decreased by exercise training in breast cancer survivors (all p < 0.01). CONCLUSIONS: Our results indicate that DKK1 and SFRP1 may be potentially useful biomarkers for evaluating the beneficial effects of long-term exercise on physical fitness and metabolism as well as the prognosis of patients with cancer. TRIAL REGISTRATION: ClinicalTrials.gov NCT02895178.
RCT Entities:
BACKGROUND: Wingless and integration site growth factor (Wnt) signaling is a tumorigenesis-related signaling pathway. Dickkpof-1 (DKK1) and secreted frizzled-related protein-1 (SFRP1) are endogenous negative regulators of Wnt/β-catenin signaling. Accumulating evidence indicates that higher serum levels of DKK1 are correlated with poor prognosis of various types of cancer. Here, we investigated whether exercise training causes changes in the serum levels of DKK1 and SFRP1 in patients with breast cancer. METHODS: Twenty-four breast cancer survivors, after chemo- or radiotherapy, participated in this single-blind randomized, controlled pilot study. Subjects were randomized to either an exercise program or a control group for 12 weeks and completed pre- and post-training tests for health-related fitness and body composition as well as blood biomarkers. The serum levels of DKK1 and SFRP1 were measured using enzyme-linked immunosorbent assay as the primary outcome. RESULTS: Exercise training for 12 weeks remarkably increased muscle strength, endurance, and flexibility and decreased body fat percentage, waist circumference, and visceral fat area (all p < 0.05). Exercise training lowered serum insulin levels and leptin/adiponectin ratios (all p < 0.05). The levels of DKK1 and SFRP1 were also significantly decreased by exercise training in breast cancer survivors (all p < 0.01). CONCLUSIONS: Our results indicate that DKK1 and SFRP1 may be potentially useful biomarkers for evaluating the beneficial effects of long-term exercise on physical fitness and metabolism as well as the prognosis of patients with cancer. TRIAL REGISTRATION: ClinicalTrials.gov NCT02895178.
Authors: Christie A Befort; Jennifer R Klemp; Heather L Austin; Michael G Perri; Kathryn H Schmitz; Debra K Sullivan; Carol J Fabian Journal: Breast Cancer Res Treat Date: 2011-12-25 Impact factor: 4.872
Authors: Rohit Surana; Sakshi Sikka; Wanpei Cai; Eun Myoung Shin; Sudha R Warrier; Hong Jie Gabriel Tan; Frank Arfuso; Simon A Fox; Arun M Dharmarajan; Alan Prem Kumar Journal: Biochim Biophys Acta Date: 2013-12-05
Authors: Katharina Kerschan-Schindl; Markus M Thalmann; Elisabeth Weiss; Maria Tsironi; Ursula Föger-Samwald; Johann Meinhart; Katerina Skenderi; Peter Pietschmann Journal: PLoS One Date: 2015-07-06 Impact factor: 3.240
Authors: H Suzuki; M Toyota; H Carraway; H Caraway; E Gabrielson; T Ohmura; T Fujikane; N Nishikawa; Y Sogabe; M Nojima; T Sonoda; M Mori; K Hirata; K Imai; Y Shinomura; S B Baylin; T Tokino Journal: Br J Cancer Date: 2008-02-19 Impact factor: 7.640
Authors: Xiangru Xu; Ming Zhan; Wenzhen Duan; Vinayakumar Prabhu; Randall Brenneman; William Wood; Jeff Firman; Huai Li; Peisu Zhang; Carol Ibe; Alan B Zonderman; Dan L Longo; Suresh Poosala; Kevin G Becker; Mark P Mattson Journal: Genome Biol Date: 2007 Impact factor: 13.583
Authors: Rebecca R Turner; Liz Steed; Helen Quirk; Rosa U Greasley; John M Saxton; Stephanie Jc Taylor; Derek J Rosario; Mohamed A Thaha; Liam Bourke Journal: Cochrane Database Syst Rev Date: 2018-09-19
Authors: Daniel Castillo; Juan Manuel Gálvez; Luis Javier Herrera; Belén San Román; Fernando Rojas; Ignacio Rojas Journal: BMC Bioinformatics Date: 2017-11-21 Impact factor: 3.169